Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 9/20 | 0.49 |
| ▸ | CNR2 | P34972 | 9/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.49 |
| ▸ | LDHA | P00338 | 2/20 | 0.49 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.49 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.49 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31759056 | 1.00 | CNR1 (0.49) | CNR1CNR2TRPV1LDHATRPM8 | |
| SCHEMBL25367932 | 0.80 | DAO (0.40) | CNR1CNR2PTGS2HPGD | |
| SCHEMBL31056925 | 0.75 | CNR1 (0.51) | CNR1CNR2SLC6A3NR1I2GLRA1 | |
| SCHEMBL21821203 | 0.74 | CNR2 (0.49) | CNR1CNR2TRPV1LDHATRPM8 | |
| SCHEMBL31056759 | 0.74 | CNR2 (0.49) | CNR1CNR2TRPV1LDHATRPM8 | |
| SCHEMBL22069530 | 0.73 | CNR2 (0.67) | CNR1CNR2TRPV1LDHATRPM8 | |
| SCHEMBL22942198 | 0.69 | TRPV1 (0.50) | CNR1CNR2TRPV1LDHATRPM8 | |
| SCHEMBL31545281 | 0.69 | TRPV1 (0.50) | CNR1CNR2TRPV1LDHATRPM8 | |
| SCHEMBL6356508 | 0.69 | PTGS2 (0.65) | TRPV1SLC6A2SLC6A4SLC6A3PTGS2 | |
| SCHEMBL5788838 | 0.67 | PTGS2 (0.67) | SLC6A2SLC6A4SLC6A3PTGS2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007688-A1 | SYNTHETIC ANALOGS OF CANNABINOL (CBN) FOR THE TREATMENT OF AGERELATED NEUROLOGICAL DISORDERS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2026-01-08 | — | — | US | claimed |
| WO-2024148193-A1 | SYNTHETIC ANALOGS OF CANNABINOL (CBN) FOR THE TREATMENT OF AGE-RELATED NEUROLOGICAL DISORDERS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2024-07-11 | — | — | WO | claimed |
| US-20260007688-A1 | SYNTHETIC ANALOGS OF CANNABINOL (CBN) FOR THE TREATMENT OF AGERELATED NEUROLOGICAL DISORDERS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2026-01-08 | — | — | US | disclosed |
| WO-2024148193-A1 | SYNTHETIC ANALOGS OF CANNABINOL (CBN) FOR THE TREATMENT OF AGE-RELATED NEUROLOGICAL DISORDERS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2024-07-11 | — | — | WO | disclosed |
| EP-3666765-A1 | CHROMENIC PHYTOCANNABINOIDS, THEIR SYNTHESIS AND USE IN TREATMENT OR PREVENTION OF DISEASE | Emerald Health Biotechnology España,S.L.U. (ES) | 2020-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007688-A1 | SYNTHETIC ANALOGS OF CANNABINOL (CBN) FOR THE TREATMENT OF AGERELATED NEUROLOGICAL DISORDERS | AIFM2, FECH, NLN | CNR1 5/4885CNR2 4/4885TRPV1 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.